• About us
    • About ImaBiotech
    • Our team
    • Quality Engagement
    • Careers
    • Contact Imabiotech
  • Innovative platforms
    • Overview of Technologies
    • Mass Spectrometry Imaging
    • Laser Microdissection
    • Multimaging™ Software
    • Spatially Resolved Gene Expression
    • High Multiplexing Proteins & Cell Markers
    • Testing Panels
  • Therapeutic areas
    • Oncology
    • Dermatology
    • Ophthalmology
    • Respiratory diseases
    • Central Nervous System
    • Metabolic Disorders
  • Services
    • Overview of Services
    • Biodistribution
    • Biomarkers Discovery
    • Formulation Screening
    • Digital Pathology Services
    • Drug Delivery
    • PK/PD-Pharmacology
    • Safety support
    • Translational Research
    • Clinical Drug Efficacy
  • Resources
    • Conferences and Webinars
    • Articles and research
    • Press releases & In the Press
    • Imabiotech news

Category: Press releases & In the Press

  • French firms partner to provide pet cancer drug services

  • ImaBiotech boosts its strategic partnerships

  • press-release

    PR: Metabrain Research and ImaBiotech initiate a strategic partnership to offer cutting-edge preclinical research services in metabolic disorders.

  • press-release

    PR: OCR and ImaBiotech initiate a strategic partnership to provide in situ drug efficacy and target exposure services in Pets with naturally occurring tumors

  • Press: ImaBiotech poursuit son développement sur le Parc Eurasanté

« Previous 1 2 3 4 5 … 13 Next »

Search news




© ImaBiotech 2018-2022

Build Your Pathway